Human Placenta-Derived Mesenchymal Stromal-Like Cells Enhance Angiogenesis via T Cell-Dependent Reprogramming of Macrophage Differentiation.

Autor: He S; Celgene Cellular Therapeutics, Warren, New Jersey, USA., Gleason J; Celgene Cellular Therapeutics, Warren, New Jersey, USA., Fik-Rymarkiewicz E; Celgene Cellular Therapeutics, Warren, New Jersey, USA., DiFiglia A; Celgene Cellular Therapeutics, Warren, New Jersey, USA., Bharathan M; Celgene Cellular Therapeutics, Warren, New Jersey, USA., Morschauser A; Celgene Cellular Therapeutics, Warren, New Jersey, USA., Djuretic I; Celgene Cellular Therapeutics, Warren, New Jersey, USA., Xu Y; Invivotek, Hamilton, New Jersey, USA., Krakovsky M; Pharmaseed, Ness-Ziona, Israel., Jankovic V; Celgene Cellular Therapeutics, Warren, New Jersey, USA., Buensuceso C; Celgene Cellular Therapeutics, Warren, New Jersey, USA., Edinger J; Celgene Cellular Therapeutics, Warren, New Jersey, USA., Herzberg U; Celgene Cellular Therapeutics, Warren, New Jersey, USA., Hofgartner W; Celgene Cellular Therapeutics, Warren, New Jersey, USA., Hariri R; Celgene Cellular Therapeutics, Warren, New Jersey, USA.

Publikováno v: Stem cells (Dayton, Ohio) [Stem Cells] 2017 Jun; Vol. 35 (6), pp. 1603-1613. Date of Electronic Publication: 2017 Mar 14.

Angiogenic properties of human placenta-derived adherent cells and efficacy in hindlimb ischemia.

Autor: Francki A; Research & Development Department, Celgene Cellular Therapeutics, Warren, NJ. Electronic address: afrancki@celgene.com., Labazzo K; Research & Development Department, Celgene Cellular Therapeutics, Warren, NJ., He S; Research & Development Department, Celgene Cellular Therapeutics, Warren, NJ., Baum EZ; Research & Development Department, Celgene Cellular Therapeutics, Warren, NJ., Abbot SE; Research & Development Department, Celgene Cellular Therapeutics, Warren, NJ., Herzberg U; Research & Development Department, Celgene Cellular Therapeutics, Warren, NJ., Hofgartner W; Research & Development Department, Celgene Cellular Therapeutics, Warren, NJ., Hariri R; Research & Development Department, Celgene Cellular Therapeutics, Warren, NJ.

Publikováno v: Journal of vascular surgery [J Vasc Surg] 2016 Sep; Vol. 64 (3), pp. 746-756.e1. Date of Electronic Publication: 2015 Jun 06.

Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy.

Autor: Kang L; Celgene Cellular Therapeutics Warren, NJ, USA., Voskinarian-Berse V, Law E, Reddin T, Bhatia M, Hariri A, Ning Y, Dong D, Maguire T, Yarmush M, Hofgartner W, Abbot S, Zhang X, Hariri R

Publikováno v: Frontiers in immunology [Front Immunol] 2013 May 01; Vol. 4, pp. 101. Date of Electronic Publication: 2013 May 01 (Print Publication: 2013).

The Mechanism of Cell Interaction and Response on Decellularized Human Amniotic Membrane: Implications in Wound Healing.

Autor: Bhatia M, Pereira M, Rana H, Stout B, Lewis C, Abramson S, Labazzo K, Ray C, Liu Q, Hofgartner W, Hariri R

Publikováno v: Wounds : a compendium of clinical research and practice [Wounds] 2007 Aug; Vol. 19 (8), pp. 207-17.

Comparison of different sources of mesenchymal stem cells: focus on inflammatory bowel disease.

Autor: Shi, Lihao, Chen, Leilei, Gao, Xizhuang, Sun, Xufan, Jin, Guiyuan, Yang, Yonghong, Shao, Yiming, Zhu, Fengqin, Zhou, Guangxi

Publikováno v: Inflammopharmacology; Jun2024, Vol. 32 Issue 3, p1721-1742, 22p